About Stephen Thorne
Stephen Thorne is an executive officer and promoter at Duo Oncology.
Stephen Thorne first appears on SEC filings in 2021.
Experience
This experience comes from Stephen Thorne's profile and from SEC filings. For roles taken from filings, the years are when the filings name Stephen Thorne in the role, so the role may have started earlier or lasted longer.
Duo Oncology Inc. Current
Executive officer
Board Member (2020 – Present)
2020 – Present · Pittsburgh, PA
Develops combination chemotherapy medicines for people with cancer.
KI
KaliVir Immunotherapeutics Current
Chief Scientific Officer
2020 – Present
WL
Western Oncolytics Ltd. Current
Chief Scientific Officer
2016 – Present
SU
Stanford University
Research Associate
2003 – 2007
CU
Cancer Research UK
PostDoc
2000 – 2002
UP
University of Pittsburgh
Assistant Professor
Key Colleagues at Startups
The people Stephen Thorne works with at each company, as listed on that company's latest Form D.
Duo Oncology Inc. · Form D/A, Aug 7, 2026
JH
Jing-Zhou Hou
Co-Founder and director
Sam Rothstein
CEO & Cofounder, director
Victoria Manax
Medical Officer and director
Stanley Marks
Board Chairman
SL
Song Li
Co-Founder and director
Katherine Eichinger
Chief Operating Officer
Joe Gatto
Director
LL
Lusong Luo
Member - BeOne Medicines and director